Pharmacyte biotech acquires $5 million stake in emerging women's health innovator femasys, inc.

Las vegas--(business wire)--pharmacyte biotech, inc. (nasdaq: pmcb) (“pharmacyte” or the “company”) announces it has made a $5 million investment in femasys, inc. (nasdaq:femy) (“femasys”), a biomedical company focused on meeting significant unmet needs for women worldwide. femasys offers a broad portfolio of in-office, accessible solutions, including a lead late-stage product candidate and innovative therapeutic and diagnostic products. this is the company's first investment in externally deve.
FEMY Ratings Summary
FEMY Quant Ranking